Literature DB >> 20826430

Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.

Ralf A Linker1, De-Hyung Lee, Seray Demir, Stefan Wiese, Niels Kruse, Ines Siglienti, Ellen Gerhardt, Harald Neumann, Michael Sendtner, Fred Lühder, Ralf Gold.   

Abstract

Brain-derived neurotrophic factor plays a key role in neuronal and axonal survival. Brain-derived neurotrophic factor is expressed in the immune cells in lesions of experimental autoimmune encephalomyelitis and multiple sclerosis, thus potentially mediating neuroprotective effects. We investigated the functional role of brain-derived neurotrophic factor in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Mice deficient for brain-derived neurotrophic factor in immune cells displayed an attenuated immune response in the acute phase of experimental autoimmune encephalomyelitis, but progressive disability with enhanced axonal loss in the chronic phase of the disease. In mice deficient for central nervous system-derived brain-derived neurotrophic factor via glial fibrillary acidic protein-crescentin-mediated deletion, a more severe course of experimental autoimmune encephalomyelitis and an overall increased axonal loss was observed. In a lentiviral approach, injection of brain-derived neurotrophic factor-overexpressing T cells led to a less severe course of experimental autoimmune encephalomyelitis and direct axonal protection. Our data imply a functional role of brain-derived neurotrophic factor in autoimmune demyelination by mediating axon protection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826430     DOI: 10.1093/brain/awq179

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  77 in total

1.  Mechanisms Involved in the Remyelinating Effect of Sildenafil.

Authors:  Daniela Díaz-Lucena; María Gutierrez-Mecinas; Beatriz Moreno; José Lupicinio Martínez-Sánchez; Paula Pifarré; Agustina García
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-03       Impact factor: 4.147

Review 2.  No quiet surrender: molecular guardians in multiple sclerosis brain.

Authors:  Lawrence Steinman
Journal:  J Clin Invest       Date:  2015-04-01       Impact factor: 14.808

3.  Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis.

Authors:  Aaron Boster; Mary Pat Bartoszek; Colleen O'Connell; David Pitt; Michael Racke
Journal:  Ther Adv Neurol Disord       Date:  2011-09       Impact factor: 6.570

Review 4.  Managing MS in a changing treatment landscape.

Authors:  Martin Duddy; Aiden Haghikia; Eleonora Cocco; Christian Eggers; Jelena Drulovic; Olga Carmona; Helene Zéphir; Ralf Gold
Journal:  J Neurol       Date:  2011-03-25       Impact factor: 4.849

5.  Stimulation of adult oligodendrogenesis by myelin-specific T cells.

Authors:  Helle Hvilsted Nielsen; Henrik Toft-Hansen; Kate Lykke Lambertsen; Trevor Owens; Bente Finsen
Journal:  Am J Pathol       Date:  2011-08-26       Impact factor: 4.307

6.  Local Injection of Lenti-BDNF at the Lesion Site Promotes M2 Macrophage Polarization and Inhibits Inflammatory Response After Spinal Cord Injury in Mice.

Authors:  Xin-Chao Ji; Yuan-Yuan Dang; Hong-Yan Gao; Zhao-Tao Wang; Mou Gao; Yi Yang; Hong-Tian Zhang; Ru-Xiang Xu
Journal:  Cell Mol Neurobiol       Date:  2015-04-04       Impact factor: 5.046

7.  Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets.

Authors:  Vamshi K Nimmagadda; Christopher T Bever; Narasimha R Vattikunta; Saifi Talat; Vakas Ahmad; Naveen K Nagalla; David Trisler; Susan I V Judge; Walter Royal; Krish Chandrasekaran; James W Russell; Tapas K Makar
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

Review 8.  T cells in the central nervous system: messengers of destruction or purveyors of protection?

Authors:  James T Walsh; Nikki Watson; Jonathan Kipnis
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

9.  Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels.

Authors:  Marta Pedreño; Maria Morell; Gema Robledo; Luciana Souza-Moreira; Irene Forte-Lago; Marta Caro; Francisco O'Valle; Doina Ganea; Elena Gonzalez-Rey
Journal:  Brain Behav Immun       Date:  2013-12-07       Impact factor: 7.217

10.  Axonal transport rate decreased at the onset of optic neuritis in EAE mice.

Authors:  Tsen-Hsuan Lin; Joong Hee Kim; Carlos Perez-Torres; Chia-Wen Chiang; Kathryn Trinkaus; Anne H Cross; Sheng-Kwei Song
Journal:  Neuroimage       Date:  2014-06-14       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.